Mycostatin Articles
AstraZeneca enrolls vandetanib Ph III trial in NSCLC
17 March 2008
US FDA clears Auriga's Liquadd for ADHD
17 March 2008
Eisai's Vasolan gets expanded Japanese indication
10 March 2008
New data indicates curcumin's lack of clinical efficacy in treatment of plaque psoriasis
10 March 2008
Crucell to manufacture parts of Wyeth vaccine
10 March 2008
Sciele and Sanofi extend Allergra accord
10 March 2008
US court rules patent for Yasmin is invalid
10 March 2008
GSK/Ligand's Promacta to get FDA priority review
10 March 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
Sinclair loss reduced 50% in 1H FY 2007
10 March 2008
FDA OKs Nexium for GERD in one-11 year olds
3 March 2008
Non-binding EMEA opinion for EpiCept's Ceplene
3 March 2008
NICE/NCCAC issue new OA care guidelines
3 March 2008
Strong Ph II NSCLC data on Agennix' talactoferrin
3 March 2008
FDA accepts Barr's Lo Seasonique NDA
3 March 2008
Pharmacopeia completes recruitment in Ph IIa study
3 March 2008
EMEA accepts Otsuka's tolvaptan MAA
3 March 2008
Novartis' Eucreas cleared in EU
3 March 2008
Actelion drops EMEA indication extension for Zavesca
3 March 2008
Xyzal oral solution cleared by US FDA
25 February 2008
Ardana unveils plans to seek buyer
25 February 2008
Sunesis gets milestone in J&J accord
25 February 2008
FDA panel recommends GSK's rotavirus vacc
25 February 2008
Zegerid launched in P Rico and Virgin Is
25 February 2008
Shionogi close to US Ph II results on obesity drug
25 February 2008
Pfizer to buy Encysive for $195M, gains Thelin
25 February 2008
US FDA to decide on approving GSK's Rotarix
25 February 2008
Cephalon's 2007 sales beat its expectations
25 February 2008
Fujifilm buying Toyama for up to $1.46B
25 February 2008
Helsinn licenses Aloxi and Gelclair to Riemser Arzneimittel
18 February 2008
Schering-Plough/OraSure in hep C test accord
18 February 2008
APP gets US approval for generic Cafcit
18 February 2008
Hollis-Eden's Triolex enters Ph I/II trial
18 February 2008
Pharmacopeia's CCR1 blocker begins lab testing
18 February 2008
Basilea's 2007 loss up 55% on trial costs
18 February 2008
FDA c'tee recommends Zyprexa LAI approval
18 February 2008
Isentress: significant HIV load suppression up to 48 weeks
18 February 2008
Generex progresses Ph III Oral-lyn trial
14 February 2008
EMEA approves Boeh Ing's oral anticoagulant
14 February 2008
Roche's Xeloda gets EC OK for bowel cancer
14 February 2008
MI risk in ACS doubles after Plavix stopped
14 February 2008
GSK's Hycamtin gets opinion from EMEA for SCLC
11 February 2008
US IDSA's IFI guidelines recommend S-P's Noxafil
11 February 2008
EC grants Xeloda broad approval for mCRC
11 February 2008
GSK licenses Amira FLAP blockers in $425M deal
11 February 2008
Encysive launches Thelin in Sweden
11 February 2008
BTG's migraine drug enters Ph I
4 February 2008
EMEA: No change to Gardasil labeling
4 February 2008
FDA clears Merck & Co's Emend Injection for CINV
4 February 2008
Myriad's MPC-0920 performs well at Ph I
4 February 2008
Vioxx costs see Merck & Co swing to $1.6B loss
4 February 2008
Clexane, and Nexavar in RCC approved in Japan
4 February 2008
Xanthus' oral fludarabine NDA accepted by FDA
4 February 2008
Naturex reviews fat burning data on Svetol
28 January 2008
Barr/Ortho OC litigation postponed
28 January 2008
Actelion's FY 2007 net revenues beat forecasts
28 January 2008
Wales' drug authority recommends Sprycel
28 January 2008
Boeh Ing's RE-LY trial completes enrollment
21 January 2008
Oramed oral insulin product completes Ph Ia trial
21 January 2008
Inspire drops out of accord on FAES Farma's bilastine
21 January 2008
Encysive launches Thelin in Belgium and Luxembourg
21 January 2008
Japan stock market week toJan 14, 2008
21 January 2008
China's Benda Pharma expands capacity
21 January 2008
Daiichi Sankyo and Eli Lilly submit NDA to US FDA for prasugrel; to be sold as Effient
14 January 2008
Pharmion/MethylGene begin combined MGCD0103/Vidaza trial
14 January 2008
Tokyo stocks to January 7, 2008
14 January 2008
Amneal completes generic drug plant acquisition
7 January 2008
Cyclacel opens Ph II sapacitabine trial in AML
7 January 2008
FDA accepts NDA for Otsuka's tolvaptan
7 January 2008
Nanoloymf created as spin-out from Hebrew University
7 January 2008
GSK's Tyverb gets nod from CHMP
24 December 2007
Encysive jumps 17% on higher Thelin guidance
24 December 2007
Otsuka buys PDL's Busulfex for $200M
24 December 2007
Shire licenses Alba's GI drug in $325M deal
24 December 2007
Encouraging early data on S*BIO's pipeline
24 December 2007
Neoadjuvant Xeloda reduces breast tumor size in Ph II trial
24 December 2007
Galvus gets positive opinion from CHMP
24 December 2007
Barr unit sues Watson and Sandoz over Seasonale patent
24 December 2007
GSK's Requip Modutab approved in 8 EU countries
17 December 2007
Requip gets US FDA "approvable" letter
17 December 2007
Generex to import insulin spray into Abu Dhabi
17 December 2007
GSK defends Avandia against findings of CV risk by ICES group
17 December 2007
Enrollment complete in Ph II/III DuoCort trial
17 December 2007
FDA pre-emption case at the US Supreme Court
17 December 2007
Boeh Ing to study dabigatran etexilate in ACS
17 December 2007
Rivaroxaban cuts VTE risk in RECORD-1 trial
17 December 2007
Dia-B Tech's ISF402 achieves encouraging Ph I data
10 December 2007
Immtech's PCP drug licensed to BioAlliance
10 December 2007
Bayer submits new oral combo contraceptive
10 December 2007
GSK's Promacta raises platelet levels
10 December 2007
Rotarix provides broad protection in EU trial
3 December 2007
Pipex enters CRADA for Coprexa in HD
3 December 2007
Bone initiates first oral osteo drug trial in Australia
26 November 2007
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
